GUGGENHEIM CAPITAL LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$457,000
+15.1%
11,674
-5.1%
0.00%
+33.3%
Q2 2022$397,000
-0.3%
12,303
+2.4%
0.00%
+50.0%
Q1 2022$398,000
-21.8%
12,019
+0.4%
0.00%
-33.3%
Q4 2021$509,000
-78.3%
11,976
-77.4%
0.00%
-78.6%
Q3 2021$2,348,000
-2.4%
52,994
+25.1%
0.01%0.0%
Q2 2021$2,406,000
-15.9%
42,353
+10.8%
0.01%
-26.3%
Q1 2021$2,862,000
+2.0%
38,234
+17.8%
0.02%
+5.6%
Q4 2020$2,807,000
+90.7%
32,445
+34.7%
0.02%
+63.6%
Q3 2020$1,472,000
+46.9%
24,0870.0%0.01%
+37.5%
Q2 2020$1,002,000
+44.8%
24,0870.0%0.01%
+14.3%
Q1 2020$692,000
-60.2%
24,0870.0%0.01%
-46.2%
Q4 2019$1,739,000
-48.5%
24,0870.0%0.01%
-51.9%
Q3 2019$3,379,000
-27.6%
24,087
-5.5%
0.03%
-28.9%
Q2 2019$4,665,000
-8.4%
25,480
-20.4%
0.04%
-7.3%
Q1 2019$5,091,000
+41.9%
32,011
-14.5%
0.04%
+36.7%
Q4 2018$3,587,000
-23.9%
37,443
+12.3%
0.03%
-3.2%
Q3 2018$4,711,000
-6.1%
33,350
+4.1%
0.03%
-6.1%
Q2 2018$5,015,000
-18.8%
32,040
-16.4%
0.03%
+120.0%
Q1 2018$6,175,000
-1.9%
38,338
+0.3%
0.02%0.0%
Q4 2017$6,292,000
+20.1%
38,205
-54.6%
0.02%
+25.0%
Q3 2017$5,238,000
+14.3%
84,088
+46.2%
0.01%0.0%
Q2 2017$4,583,000
-2.7%
57,529
-13.1%
0.01%
-7.7%
Q1 2017$4,709,000
+15.3%
66,227
-17.2%
0.01%
+8.3%
Q4 2016$4,085,000
+46.6%
80,010
+32.2%
0.01%
+33.3%
Q3 2016$2,786,000
+25.9%
60,509
-12.3%
0.01%
+28.6%
Q1 2016$2,213,000
-45.1%
69,028
-0.2%
0.01%
-41.7%
Q4 2015$4,032,000
-8.5%
69,160
-33.6%
0.01%
-14.3%
Q3 2015$4,408,000
+98.4%
104,163
+242.2%
0.01%
+180.0%
Q2 2015$2,222,00030,4410.01%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders